Spine accounts for 18.2% of the orthopedic industry’s overall revenue. We project the segment to hold steady in the mid-2% growth range through 2023. Let’s take a deeper look at the players driving that performance.

Marc Viscogliosi, Principal at Viscogliosi Brothers, says that factors like industry and surgeon desires for innovation, the capability of 3D printing and the commitment from FDA to approve more products and procedures are leading to advancements not seen in two decades.

With the NASS 2019 Annual Meeting approaching, we’re taking time to revisit spine products that have gained FDA 510(k) clearance in the first half of the year. This round-up shares another entrant into the SI joint arena, an implant company’s first clearance for a surgical enabling technology and additional details about some lesser-known companies to watch.

Combined, the 15 companies featured in our infographic account for 86% of the global spine market's $9.3 billion revenue.
Available for download:

2019 Highlights Include:
Industry and Surgeon Perspectives
Deeper Revenue and Market Share Data for Companies >$100 Million
Downloadable Revenue and Market Share Exhibits in Excel
Exhibit: Growth Rates for 10 Largest Companies

The 19 funding announcements from 1H19 spanned all market segments of the orthopedic industry fairly evenly. We review the players that received capital and their plans for deploying the money.

Robotics remains a polarizing topic amongst orthopedic surgeons. OMTEC 2019 provided a stage for the continued debate, with active robotic users calling for technology advancements and a non-user cautioning against adoption without data.
This eNewsletter is published by ORTHOWORLD Inc. and is available to Members of ORTHOWORLD or by email subscription . Copyright © 2019. All rights reserved.

Carolyn LaWell, Chief Content Officer |
Julie A. Vetalice, Editorial Assistant |